Valuation Charles River Laboratories International, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 08/05/2026 BST			5-day change	1st Jan Change
177.62 ^USD	-2.23%		+7.14%	-10.96%

05-08	Charles River Laboratories International, Inc. Seeks M&A Opportunities	CI
05-07	Tranche Update on Charles River Laboratories International, Inc.'s Equity Buyback Plan announced on November 5, 2025.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	18,941	11,138	12,252	9,520	10,023	8,556	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-14.64%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,362	9,865	9,400
Change	-	-36.28%	7.39%	-20.91%	3.29%	-13.26%	-4.79%	-4.72%
P/E ratio	49.4x	23.1x	25.9x	931x	-70x	27.7x	20.1x	17.5x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.62x	2.38x	2.15x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.5x	1.2x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.22x	2.17x	2.08x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.69x	2.51x	2.28x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	10.3x	9.35x	8.35x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	12.7x	11.1x	9.97x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	24.7x	19.5x	23.9x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	4.05%	5.12%	4.18%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.403	8.847	10.13
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,850	3,935	4,117
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,001	1,055	1,126
EBIT ¹	742.1	834	838.8	805.9	793.9	812.9	885.9	942.8
Net income ¹	391	486.2	474.6	10.3	-144.3	310.9	435.9	450.9
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,806	1,310	844.2
Reference price ²	375.34	218.92	238.84	186.16	203.66	177.62	177.62	177.62
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	27.74x	2.67x	10.27x	-.--%	8.56B
LONZA GROUP AG	29.29x	5.18x	16.05x	1.12%	43.39B
BEONE MEDICINES AG	47.3x	4.76x	30.21x	-.--%	34.7B
REVOLUTION MEDICINES, INC.	-17.93x	275.37x	-16.05x	-.--%	30.15B
IQVIA HOLDINGS INC.	21.76x	2.53x	10.94x	-.--%	29.83B
CELLTRION, INC.	31.84x	8.18x	20.96x	0.4%	28.46B
IONIS PHARMACEUTICALS, INC.	-21.32x	13.76x	-21.38x	-.--%	12.51B
EUROFINS SCIENTIFIC SE	20.79x	1.84x	8.08x	1.29%	12.29B
Average	17.44x	39.29x	7.39x	0.35%	24.98B
Weighted average by Cap.	20.78x	46.12x	10.52x	0.38%